The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide

被引:36
|
作者
Siddiqui, AH
Harris, AD
Hebden, J
Wilson, PD
Morris, JG
Roghmann, MC
机构
[1] VA Maryland Hlth Care Syst, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Healthcare Outcomes Res, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[4] Univ Maryland, Med Syst, Baltimore, MD 21201 USA
关键词
D O I
10.1067/mic.2002.118616
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Vancomycin-resistant enterococci (VRE) have become a major cause of nosocomial Infections and are now endemic in many geographic areas, The aim of this study was to describe the effect of active surveillance for patients with VRE in high-risk units on the VRE incidence rate hospital-wide. Methods: We determined 4 time periods based on the intervention of active surveillance: preactive surveillance (period 1), active surveillance (period 2), no active surveillance (period 3), and reinstutition of active surveillance (period 4). VRE incidence rates based on first clinical culture for VRE per 10,000 patient days for each of these periods and incidence rate ratios were then calculated. Results: Active surveillance in high-risk units was associated with a significant reduction in VRE incidence hospital-wide in 2 of the 3 comparisons made. The incidence rate ratio when comparing the first period of active surveillance (period 2) to the preactive surveillance period (period 1) was 0.63 (95 % Cl, 0.38-1.1) it was 0.36 (95 % Cl, 0.23-0.55) when comparing the first period of active surveillance (period 2) to the subsequent period (period 3) and 0.68 (95% Cl, 0.54-0.85) when comparing the second period of active surveillance (period 4) to the prior period without active surveillance periods, Conclusions: Active surveillance culturing for VRE in the high risk-units prevented further VRE transmission, as evidenced by a significant increase in hospital-wide incidence rates when active surveillance was discontinued and a significant decrease in incidence rates when it was restarted.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 50 条
  • [41] Effect of linezolid on the occurrence of vancomycin-resistant enterococci
    Eiland, Edward H., III
    Robinson, Jennifer B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (24) : 2535 - 2536
  • [42] Vancomycin-resistant enterococci: Risk related to the use of intravenous vancomycin in a university hospital
    Fuller, RE
    Harrell, LJ
    Meredith, FT
    Sexton, DJ
    Colvin, LG
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (11): : 821 - 823
  • [43] Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital
    MacIntyre, CR
    Empson, M
    Boardman, C
    Sindhusake, D
    Lokan, J
    Brown, GV
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (10): : 624 - 629
  • [44] Blossoming vancomycin-resistant enterococci infections
    Garvey, M. I.
    Bradley, C. W.
    Holden, E.
    JOURNAL OF HOSPITAL INFECTION, 2017, 97 (04) : 421 - 423
  • [45] Osteomyelitis attributable to vancomycin-resistant enterococci
    Holtom, PA
    Zamorano, D
    Patzakis, MJ
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2002, (403) : 38 - 44
  • [46] Vancomycin-resistant enterococci in turkeys and farmers
    vandenBogaard, AE
    Jensen, LB
    Stobberingh, EE
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21): : 1558 - 1559
  • [47] Management of patients with vancomycin-resistant enterococci
    Morris, JG
    Roghmann, MC
    Schwalbe, R
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2000, 9 (01) : 10 - 16
  • [48] Vancomycin-resistant enterococci in pediatric patients
    不详
    INFECTION, 2005, 33 (03) : 177 - 177
  • [49] Prevalence of vancomycin-resistant enterococci in Europe
    Schouten, MA
    Hoogkamp-Korstanje, JAA
    Meis, JFG
    Voss, A
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (11) : 816 - 822
  • [50] The changing epidemiology of vancomycin-resistant enterococci
    Lai, KK
    Fontecchio, SA
    Kelley, AL
    Baker, S
    Melvin, ZS
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (04): : 264 - 268